Holen Sie sich die Stockscreener-App
0.70
11.13%
0.0701
Handel nachbörslich:
.72
0.02
+2.86%
Schlusskurs vom Vortag:
$0.6299
Offen:
$0.63
24-Stunden-Volumen:
2.86M
Relative Volume:
5.39
Marktkapitalisierung:
$17.07M
Einnahmen:
$49.59M
Nettoeinkommen (Verlust:
$-15.61M
KGV:
-0.1222
EPS:
-5.7281
Netto-Cashflow:
$-32.55M
1W Leistung:
-0.71%
1M Leistung:
-11.66%
6M Leistung:
+1.16%
1J Leistung:
-35.19%
1-Tages-Spanne:
$0.609
$0.7599
1-Wochen-Bereich:
$0.54
$0.7599
52-Wochen-Spanne:
$0.4677
$1.65
Cosmos Health Inc Stock (COSM) Company Profile
Firmenname
Cosmos Health Inc
Sektor
Branche
Telefon
312-536-3102
Adresse
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Vergleichen Sie COSM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| COSM | 0.70 | 17.07M | 49.59M | -15.61M | -32.55M | -5.7281 |
| MCK | 615.60 | 79.62B | 330.19B | 2.54B | 4.31B | 25.31 |
| COR | 242.87 | 47.83B | 293.96B | 1.51B | 3.00B | 8.53 |
| CAH | 120.03 | 29.14B | 224.34B | 1.26B | 1.08B | 0.61 |
| HSIC | 73.89 | 9.36B | 12.50B | 314.00M | 421.00M | 3.42 |
| PDCO | 20.90 | 1.83B | 6.57B | 185.93M | -857.00M | 2.19 |
Cosmos Health Inc Aktie (COSM) Neueste Nachrichten
Another Publicly Traded Company Adds Bitcoin to Its Balance Sheet - Decrypt
Cosmos Health Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St
Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets - AccessWire
Cosmos Health reports steady Q3 financials, cuts costs - Investing.com India
Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M - AccessWire
Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gro - WICZ
ARMISTICE CAPITAL, LLC Acquires New Stake in Cosmos Health Inc - GuruFocus.com
Cosmos Health Inc. (COSM) Quarterly 10-Q Report - Quartzy
Cosmos Health Q3: Amazon UK Sales Surge 160% Despite Revenue Dip; Operating Costs Down 19% | COSM Stock News - StockTitan
Cosmos Health reports revenue growth and strategic expansions - Investing.com
Cosmos Health (COSM) Reports 18% Q1 Growth, Projects $155M Revenue by 2027 | COSM Stock News - StockTitan
Cosmos Health reports revenue growth and strategic expansions By Investing.com - Investing.com UK
Cosmos Health Issues Letter to Shareholders - AccessWire
EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East - AOL
Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21% - Big News Network
CosmoFarm reports 8.62% revenue increase in 2024 By Investing.com - Investing.com Canada
CosmoFarm reports 8.62% revenue increase in 2024 - Investing.com India
Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with - PharmiWeb.com
Cosmos Health’s Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21% - StockTitan
Cointreau Is Shaking Up Holiday Entertaining with Limited-Edition Cointreau, Cosmos + Caviar Kit - Yahoo Finance
Cosmos Health (NASDAQ:COSM) versus Sinopharm Group (OTCMKTS:SHTDF) Financial Contrast - Defense World
Head to Head Survey: Cosmos Health (NASDAQ:COSM) and Sinopharm Group (OTCMKTS:SHTDY) - Defense World
Cosmos Healthcare Introduces Neuromap® and QPAN Model: AI-Driven Personalized Care for Autism & Neurological - EIN News
Virax Biolabs Group Limited Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland - Marketscreener.com
Contrasting Sinopharm Group (OTCMKTS:SHTDF) & Cosmos Health (NASDAQ:COSM) - Defense World
Analyzing McKesson Europe (OTCMKTS:CAKFY) and Cosmos Health (NASDAQ:COSM) - Defense World
Pre-market Movers: ALZN, VRAX, APDN, LQDA... - RTTNews
An Epic Dystopia - The American Prospect
Cosmos Health (NASDAQ:COSM) vs. ScripsAmerica (OTCMKTS:SCRCQ) Critical Contrast - Defense World
Taking the lead: Cosmos Health Inc (COSM) - SETE News
Evaluating COSM’s financial ratios for a profitable investment - US Post News
Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands - AccessWire
Company’s Banking Shares: Up -50.73% from 52-Week Low, But Can the Momentum Hold? - The InvestChronicle
Investor’s Delight: Cosmos Health Inc (COSM) Closes Weak at 1.01, Down -8.18 - The Dwinnex
Cosmo First expects plastic business to turn profitable by the fourth quarter this year - CNBCTV18
Cosmos Health secures UK orders for antimicrobial wash By Investing.com - Investing.com Australia
Recovery room: Skye, Corbus mend post-Novo CB1 weight-loss data - BioWorld Online
Cosmos Health secures UK orders for antimicrobial wash - Investing.com
Cosmos Health signs deal for mpox detection kits in India - Investing.com India
Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins - Lelezard
Financial Survey: ScripsAmerica (OTCMKTS:SCRCQ) versus Cosmos Health (NASDAQ:COSM) - Defense World
Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits - Lelezard
Core Scientific (NASDAQ:CORZ) Coverage Initiated at Canaccord Genuity Group - Defense World
Cosmo Pharmaceuticals Enhances Management Team with Newly Appointed Head of Global Business Development - Newsfile
Cosmos Health begins development of new GI disorder treatment By Investing.com - Investing.com Australia
Railway stock hits 5% upper circuit after receiving order worth ₹ 127.4 Cr for steel sheet piles - Trade Brains
Finanzdaten der Cosmos Health Inc-Aktie (COSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
3.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):